University of Pennsylvania gets more money if more vaccines are sold, and gets “milestone payments” when the FDA approves a Pfizer-BioNTech vaccine, according to SEC documents.
BROADCASTING FOR INDEPENDENCE
BROADCASTING FOR INDEPENDENCE
University of Pennsylvania gets more money if more vaccines are sold, and gets “milestone payments” when the FDA approves a Pfizer-BioNTech vaccine, according to SEC documents.
